Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition

Journal of Cell Biology

Volumn 171, Issue 6, 2005, Pages 1023-1034

  Irie, Hanna Y ^a,b   Pearline, Rachel V ^a   Grueneberg, Dorre ^a,c   Hsia, Maximilian ^c   Ravichandran, Preethi ^c   Kothari, Nayantara ^c   Natesan, Sridaran ^c   Brugge, Joan S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN AKT1; PROTEIN KINASE B; PROTEIN KINASE B BETA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BIOLOGICAL MARKERS; BREAST; CELL LINE; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MESODERM; MORPHOGENESIS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 29144488505     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200505087     Document Type: Article

References (45)

1. Arboleda, M.J., J.F. Lyons, F.F. Kabbinavar, M.R. Bray, B.E. Snow, R. Ayala, M. Danino, B.Y. Karlan, and D.J. Slamon. 2003. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res. 63:196-206.
2. Bae, S.S., H. Cho, J. Mu, and M.J. Birnbaum. 2003. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 278:49530-49536.
3. Barnett, S.F., M.T. Bilodeau, and C.W. Lindsley. 2005. The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation. Curr. Top. Med. Chem. 5:109-125.
4. Bellacosa, A., D. de Feo, A.K. Godwin, D.W. Bell, J.Q. Cheng, D.A. Altomare, M. Wan, L. Dubeau, G. Scambia, V. Masciullo, et al. 1995. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer. 64:280-285.
5. Bellacosa, A., C.C. Kumar, A.D. Cristofano, and J.R. Testa. 2005. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv. Cancer Res. 94:29-86.
6. Brazil, D.P., Z.Z. Yang, and B.A. Hemmings. 2004. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29:233-242.
7. Cho, H., J. Mu, J.K. Kim, J.L. Thorvaldsen, Q. Chu, E.B. Crenshaw III, K.H. Kaestner, M.S. Bartolomei, G.I. Shulman, and M.J. Birnbaum. 2001a. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 292:1728-1731.
8. Cho, H., J.L. Thorvaldsen, Q. Chu, F. Feng, and M.J. Birnbaum. 2001b. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276:38349-38352.
9. Choi, W.S., and C.K. Sung. 2004. Inhibition of phosphatidylinositol-3- kinase enhances insulin stimulation of insulin receptor substrate 1 tyrosine phosphorylation and extracellular signal-regulated kinases in mouse R-fibroblasts. J. Recept. Signal Transduct. Res. 24:67-83.
10. Craparo, A., T.J. O'Neill, and T.A. Gustafson. 1995. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine- dependent interaction with the NPEY motif of the insulin-like growth factor I receptor. J. Biol. Chem. 270:15639-15643.
11. Debnath, J., K.R. Mills, N.L. Collins, M.J. Reginato, S.K. Muthuswamy, and J.S. Brugge. 2002. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell. 111:29-40.
12. Debnath, J., S.K. Muthuswamy, and J.S. Brugge. 2003a. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 30:256-268.
13. Debnath, J., S.J. Walker, and J.S. Brugge. 2003b. Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner. J. Cell Biol. 163:315-326.
14. Eger, A., A. Stockinger, J. Park, E. Langkopf, M. Mikula, J. Gotzmann, W. Mikulits, H. Beug, and R. Foisner. 2004. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene. 23:2672-2680.
15. Figueroa, C., S. Tarras, J. Taylor, and A.B. Vojtek. 2003. Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex. J. Biol. Chem. 278:47922-47927.
16. Foulstone, E., S. Prince, O. Zaccheo, J.L. Burns, J. Harper, C. Jacobs, D. Church, and A.B. Hassan. 2005. Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J. Pathol. 205:145-153.
17. Galetic, I., S.M. Maira, M. Andjelkovic, and B.A. Hemmings. 2003. Negative regulation of ERK and Elk by protein kinase B modulates c-Fos transcription. J. Biol. Chem. 278:4416-4423.
18. Gotzmann, J., H. Huber, C. Thallinger, M. Wolschek, B. Janse, R. Schulte-Hermann, H. Beug, and W. Mikulits. 2002. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps toward invasiveness. J. Cell Sci. 115:1189-1202.
19. Grande, M., A. Franzen, J.O. Karlsson, L.E. Ericson, N.E. Heldin, and M. Nilsson. 2002. Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J. Cell Sci. 115:4227-4236.
20. Grunert, S., M. Jechlinger, and H. Beug. 2003. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 4:657-665.
21. Hutchinson, J., J. Jin, R.D. Cardiff, J.R. Woodgett, and W.J. Muller. 2001. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol. Cell. Biol. 21:2203-2212.
22. Hutchinson, J.N., J. Jin, R.D. Cardiff, J.R. Woodgett, and W.J. Muller. 2004. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res. 64:3171-3178.
23. Hynes, N.E., and H.A. Lane. 2005. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer. 5:341-354.
24. Janda, E., K. Lehmann, I. Killisch, M. Jechlinger, M. Herzig, J. Downward, H. Beug, and S. Grunert. 2002. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156:299-313.
25. Jiang, Z.Y., Q.L. Zhou, K.A. Coleman, M. Chouinard, Q. Boese, and M.P. Czech. 2003. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. USA. 100:7569-7574.
26. Katome, T., T. Obata, R. Matsushima, N. Masuyama, L.C. Cantley, Y. Gotoh, K. Kishi, H. Shiota, and Y. Ebina. 2003. Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J. Biol. Chem. 278:28312-28323.
27. Khoury, H., M.A. Naujokas, D. Zuo, V. Sangwan, M.M. Frigault, S. Petkiewicz, D.L. Dankort, W.J. Muller, and M. Park. 2005. HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion. Mol. Biol. Cell. 16:550-561.
28. Kim, A.H., H. Yano, H. Cho, D. Meyer, B. Monks, B. Margolis, M.J. Birnbaum, and M.V. Chao. 2002. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron. 35:697-709.
29. Leahy, M., A. Lyons, D. Krause, and R. O'Connor. 2004. Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251. J. Biol. Chem. 279:18306-18313.
30. Mende, I., S. Malstrom, P.N. Tsichlis, P.K. Vogt, and M. Aoki. 2001. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene. 20:4419-4423.
31. Myers, M.G., Jr., X.J. Sun, B. Cheatham, B.R. Jachna, E.M. Glasheen, J.M. Backer, and M.F. White. 1993. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology. 132:1421-1430.
32. Ory, D.S., B.A. Neugeboren, and R.C. Mulligan. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA. 93:11400-11406.
33. Park, B.K., X. Zeng, and R.I. Glazer. 2001. Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res. 61:7647-7653.
34. Parsons, D.W., T.L. Wang, Y. Samuels, A. Bardelli, J.M. Cummins, L. DeLong, N. Silliman, J. Ptak, S. Szabo, J.K. Willson, et al. 2005. Colorectal cancer: mutations in a signalling pathway. Nature. 436:792.
35. Rommel, C., B.A. Clarke, S. Zimmermann, L. Nunez, R. Rossman, K. Reid, K. Moelling, G.D. Yancopoulos, and D.J. Glass. 1999. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science. 286:1738-1741.
36. Seton-Rogers, S.E., Y. Lu, L.M. Hines, M. Koundinya, J. LaBaer, S.K. Muthuswamy, and J.S. Brugge. 2004. Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc. Natl. Acad. Sci. USA. 101:1257-1262.
37. Shaw, L.M., I. Rabinovitz, H.H. Wang, A. Toker, and A.M. Mercurio. 1997. Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell. 91:949-960.
38. Staal, S.P. 1987. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. USA. 84:5034-5037.
39. Tannheimer, S.L., S.P. Ethier, K.K. Caldwell, and S.W. Burchiel. 1998. Benzo[a]pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line. Carcinogenesis. 19:1291-1297.
40. Thiery, J.P. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15:740-746.
41. Woodgett, J.R. 2005. Recent advances in the protein kinase B signaling pathway. Curr. Opin. Cell Biol. 17:150-157.
42. Yamamoto, K., D. Altschuler, E. Wood, K. Horlick, S. Jacobs, and E.G. Lapetina. 1992. Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85. J. Biol. Chem. 267:11337-11343.
43. Yang, Z.Z., O. Tschopp, M. Hemmings-Mieszczak, J. Feng, D. Brodbeck, E. Perentes, and B.A. Hemmings. 2003. Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J. Biol. Chem. 278:32124-32131.
44. Zhou, B.P., J. Deng, W. Xia, J. Xu, Y.M. Li, M. Gunduz, and M.C. Hung. 2004. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6:931-940.
45. Zimmermann, S., and K. Moelling. 1999. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science. 286:1741-1744.